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Abstract 
Background: The Makerere University/Uganda Virus Research 
Institute (UVRI) Centre of Excellence for Infection & Immunity 
Research and Training (MUII) is a collaborative programme 
supporting excellence in Infection and Immunity (I&I) research in 
Uganda. Set up in 2008, MUII aims to produce internationally 
competitive Ugandan and East African I&I research leaders, and 
develop human and infrastructural resources to support research and 
training excellence. We undertook an internal evaluation of MUII’s 
achievements, challenges and lessons learned between 08-2008 and 
12-2019, to inform programmes seeking to build Africa’s health 
research expertise. 
Methods: Quantitative data were abstracted from programme annual 
reports. Qualitative data were obtained in 03-04/2019: a cross-
sectional evaluation was undertaken among a purposefully selected 
representative sample of 27 trainees and two programme staff. 
Qualitative data was analysed according to pre-determined themes of 
achievements, challenges, lessons learned and recommendations for 
improvement. 
Results: By 12-2019, MUII had supported 68 fellowships at master’s-
level and above (50% female: 23 Masters, 27 PhD, 15 post-doctoral, 
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three group-leaders) and over 1,000 internships. Fellows reported 
career advancement, mentorship by experts, and improved research 
skills and outputs. Fellows have published over 300 papers, secured 
grants worth over £20m, established over 40 international 
collaborations, and taken on research and academic leadership 
positions in the country. Key lessons were: i) Efficient administration 
provides a conducive environment for high quality research; ii) 
Institutions need supportive policies for procurement, including 
provisions for purchases of specific biological research reagents from 
international manufacturers; iii) Strong international and multi-
disciplinary collaboration provides a critical mass of expertise to 
mentor researchers in development; and iv) Mentorship catalyses 
young scientists to progress from graduate trainees to productive 
academic researchers, relevant to society’s most pressing health 
challenges. 
Conclusions: Sustainable academic productivity can be achieved 
through efficient operational support, global collaboration and 
mentorship to provide solutions to Africa’s health challenges.
Keywords 
Academic careers, capacity building for research, Infection and 
Immunity, Immunology, bioinformatics, mentorship, collaboration, 
partnership, sub-Saharan Africa
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Introduction
From its inception in 2008 as a training programme, and 
transition in 2016 to a Centre of Excellence, the Makerere 
University/Uganda Virus Research Institute (UVRI) Centre of 
Excellence for Infection & Immunity Research and Training 
(MUII) has earned a reputation for building Ugandan capacity 
in infection and immunity (I&I) research. MUII, a partner-
ship between Uganda’s leading health research institute (UVRI) 
and the country’s oldest and most prestigious university 
(Makerere University), collaborates with University of Cam-
bridge, the London School of Hygiene & Tropical Medicine 
and other partners, and is currently funded through the African 
Academy of Sciences’ DELTAS Africa Initiative1,2. MUII 
aims to provide opportunities to bright young Ugandans to 
engage in Africa-led world-class research in I&I to provide 
solutions for Africa’s health challenges, and to contribute 
to improving global health. The current COVID-19 global 
crisis underscores the need for local expertise and infrastruc-
ture to support national responses to global health challenges 
within the local context.
MUII supports graduate trainees who include master’s and 
doctoral students and early career scientists [post-doctoral sci-
entists within five years after PhD award and group leaders 
(post-doctoral scientists initiating research groups in a particular 
field of interest)] in I&I disciplines. In addition, MUII pro-
vides placements for undergraduate and new-graduate interns, 
including proactive support for individuals with disability, to 
develop interest and participate in biomedical research.
Unlike recent large-capacity building programmes that have 
focused on increasing the numbers and quality of medical 
graduates to support health care in resource-limited settings3,4, 
MUII supports development of local research scientists to har-
ness cutting edge tools of immunology, molecular biology, 
genetics and bioinformatics to address the health challenges 
of tropical Africa1,2. Although PhD training has increased in 
the last decade through various collaborative programmes5, 
there is limited experience and data on growth of academic 
careers from PhD graduates to independent scientists and lead-
ers in science, policy and practice. This gap is emphasised by 
the scarcity of post-doctoral and research fellow positions in 
the establishment of several academic institutions in Uganda 
and the sub-Saharan region. We therefore found it necessary to 
systematically investigate and document the drivers of the suc-
cess, the challenges and the key lessons from MUII that might 
be useful to other research capacity building programmes 
in Uganda and similar resource-limited settings, to further 
bridge the gap between doctoral degrees and academic research 
leadership, building public utility of local scientists to lead, 
inform and solve local problems within the global context.
Methods
Programme description
MUII supports a centre of excellence in I&I research and 
training, with a secretariat based at UVRI. The secretariat 
comprises the Director, Centre Manager, finance, adminis-
tration, procurement, monitoring and evaluation, and commu-
nication teams which work in close collaboration with UVRI 
government staff. The secretariat implements, and monitors 
activities and processes that are agreed upon by the executive 
committee. The MUII secretariat also organised regular meet-
ings which made it easy for people to be accountable not only 
for their time but also to their set goals. The centre is gov-
erned by an executive committee (EC), chaired by the Direc-
tor, with representation from each category of trainees (master’s, 
PhD and post-doctoral) to guide and the implementation of the 
programme. The EC provides guidance to the secretariat in the 
execution of program activities. The programme has a Scien-
tific Advisory Board (SAB) consisting of local and international 
experts in I&I who help to review all programme activities. A 
SAB member usually chairs fellowship selection committees; and 
SAB members attend the Annual General Meeting, participat-
ing in review of fellows’ progress, programme goals, activities, 
outputs and outcomes (Figure 1).
MUII also employed scientific staff in areas requiring intensive 
support and development (initially a senior, expatriate immu-
nologist; subsequently a more junior Ugandan immunologist 
(recently graduated from an American university); both at first 
full-time, later part-time. These supported initiation of core 
training in immunology, and subsequently contributed to devel-
opment of Makerere’s master’s degree in immunology and clini-
cal microbiology, and the development of a new department of 
Immunology and Molecular Biology, chaired by a MUII post-
doctoral alumnus. Similarly, MUII has supported a lead scientist 
in bioinformatics, first as a post-doctoral fellow, subsequently 
as a part-time staff scientist. MUII offered training in research 
methods, data analysis, use of data analysis software pack-
ages, grant writing, report writing, presentation skills, among 
others.
MUII functions through core implementation teams called Impis 
(from the Zulu word for a band of warriors) which provide sup-
port for the fellows’ projects. The Impis include Immunol-
ogy, Bioinformatics, Fellowships, Mentorship, Monitoring and 
Evaluation, Internships and Diversity, as well as Community 
Engagement1,2. In addition to fellowships, MUII provides oppor-
tunities for endeavour awards to allow innovative interven-
tions and visiting scientists awards to allow fellows to invite 
or visit international experts in specific fields of interest to 
          Amendments from Version 1
The authors have added a comment on the low response rate to 
the survey [27/68 (40%)] and that could have biased the results 
if only successful trainees reported.  We were able to get both 
positive and negative reviews and reach saturation of ideas in 
the focus group discussions (FGDs) and in-depth interviews that 
were conducted. Also, we found that emerging themes from 
the trainees in FGDs were complementary to those from key 
informant interviews. The rest of the changes are editorial, in 
response to the clarifications suggested by the reviewers.
Any further responses from the reviewers can be found at 
the end of the article
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Page 3 of 16
AAS Open Research 2020, 3:26 Last updated: 17 AUG 2020
build research expertise. An executive committee chaired by 
the Director, with representation from each category of train-
ees (master’s, PhD and post-doctoral) and from each Impi, 
manages the implementation of the programme, and provides 
guidance to the secretariat in the execution of program activities.
Evaluation design and participants
We reviewed programme monitoring and evaluation data, 
including annual reports (2008–2019), for quantitative data 
on number of trainees and outputs including publications 
and research grants. Additionally, in a cross-sectional study, 
qualitative evaluation was conducted in March and April 2019 
by F.Z., a social scientist at the medical research council (with 
MSc in Gerontology) independent of the MUII programme. A 
representative sample of 27 trainees (out of 50 then available), 
and two centre staff was purposefully selected. The purposive 
representative sample considered representation of five cat-
egories of fellows: Masters, PhD, post-doctoral and group-leader 
fellows, and honorary fellows (not directly funded by MUII, 
but registered under MUII, participating in fellows’ meetings 
and training activities, and sometimes receiving small travel 
or equipment grants). The interviewer introduced herself to all 
interviewees on email, highlighted the purpose of the inter-
view and made suitable appointments. All participants con-
tacted accepted to participate in face-to-face interviews during 
working hours. The interview was attended by the interviewer, 
interviewee and two media staff to audio and video record. 
Skype interviews were conducted with participants unavail-
able for face-to-face interaction. Each interview lasted at least 
45 minutes.
Qualitative data collection
In-depth interviews (IDI) were conducted with the fellows 
and key informant interviews (KII) with staff, by using a pre-
tested topic guide (see Extended data) to explore experiences 
from the MUII programme over the last 10 years. The guide 
Figure 1. MUII Internal and External Scientific and Advisory Review Structures.
Advice and review is, and will be, provided by the Scientific Advisory Board (SAB) and by additional reviewers solicited among implementation 
colleagues (such as Ministries of Health, industry, non-governmental organisations) and expert colleagues from partner institutions (LSHTM, 
Cambridge, and collaborators. The large red arrow represents planning and progression of the programme as a whole; blue arrows represent 
recruitment and follow up of fellows and alumni. Numbers below explain those in the figure.
Advice on MUII3 programme strategy
1. The SAB participation in planning for MUII3 through 2019 and 2020 AGM and SAB meetings. Additional input from policy-makers and other 
potential “end-users” of research has been initiated, and will continue during the planning and execution of MUII3
2. The SAB review reports and progress at each future MUII3 AGM and guiding further direction
Advice on selection and progress of fellows
3. Preliminary applications long-listed by Executive and Steering Committee members
4. Expert review for each full application, usually solicited from expert collaborators beyond the SAB
5. Interview committees include SAB members and other reviewers, based on required expertise.
6. Fellows’ progress reviewed at AGMs by SAB members
7. High calibre external examiners and “opponents” for examinations
Advice for MUII’s emerging research leaders
8. Peer review and critical review by senior MUII scientists; independent expert review from scientists who are highly experienced in grantsmanship 
at LSHTM and Cambridge.
9. SAB members and other international collaborators provided mentorship for MUII fellows.
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was designed to obtain insights into achievements (both for 
the fellow and the institution), successes and career progres-
sion of trainees, growth in institutional I&I research capacity, 
sustainability, challenges, lesson learnt, recommendations for 
improvements and sustainability of the impact beyond the pro-
gramme. We also included questions on new leadership roles and 
mentorship experience that fellows have been involved in 
after participating in the MUII programme.
Qualitative data management and analysis
Qualitative interviews and Skype calls were audio-recorded 
and later transcribed verbatim. These data were underpinned 
on content analysis, coded by F.Z., and analysed thematically 
using a framework that was informed by the study objectives 
and preliminary findings, according to pre-determined themes of 
achievements, challenges, lessons learned and recommendations 
for improvement. The framework was for coding the study data 
with constant comparison across the team to ensure consistency. 
The coding of data was managed using NVivo 12.
Ethical review and consent
The protocol for the qualitative evaluation was reviewed by the 
Research Ethics Committee of the Uganda Virus Research Insti-
tute, which gave a waiver of written consent and approval to 
publish these routine program data (REF GC/127/19/03/699). 
Participants gave verbal consent to participation in the 
interviews and the use of the material from the interviews, 
including quotes, in this paper. Permission was sought from 
participants whose quotations appear in the paper.
Results
Results are presented under the major emerging themes which 
were; achievements, successes and career progression of train-
ees, growth in institutional I&I research capacity, sustainability, 
challenges, lesson learnt, and recommendations for improvements.
Achievements
MUII’s principal achievements comprise a) the successes 
and career progression of trainees, b) growth in Infection and 
Immunity (I&I) research and training capacity at MUII part-
ner institutions in Uganda, and c) establishment of sustainable 
international collaborations for young Ugandan scientists.
Successes and career progression of trainees. Between January 
2008 and December 2019, MUII supported 68 fellowships 
including 23 master’s fellows, 27 PhD fellows, 15 post-doctoral 
fellows and three group leaders in I&I research. Of these, 53 
were directly funded by MUII, while 15 were honorary fel-
lows (Table 1). By December 2019 these fellows, since joining 
MUII, had published over 300 peer-reviewed publications 
and received over 20 million Pound Sterling worth of addi-
tional funds for research (Figure 2). These were all desired 
outputs of the programme demonstrating the achievement of 
the goal, “...to allow the Fellows to develop into independ-
ently funded research leaders” (EMEL028, M, KII, Centre 
Staff). Other members of staff commented that seeing alumni 
‘take off’ and become independent was a clear mark of 
success.
All MUII alumni have taken on academic leadership roles 
including Principal Investigators, Heads of Departments, Deans 
of Schools, supervisors of graduate students, and mentors of other 
emerging scientists. MUII also supported over 1000 internships 
at UVRI and exposed over 5000 high school students to 
scientific research through “Open Days” at UVRI.
Growth in I&I research at MUII partner institutions in 
Uganda. Before MUII was launched, there were few facili-
ties for immunology research at Makerere University. Starting 
with a small immunology laboratory under the Department of 
Microbiology, MUII contributed to human, technical and physi-
cal infrastructural development in I&I capacity. MUII supported 
renovations to improve space and equipment in the Immunology 
laboratory, as well as salary support for two immunologists to 
catalyse growth. Growth occurred, as evidenced by development 
of new Masters’ and doctoral training programmes in Immu-
nology and Clinical Microbiology and in Genomics and Bioin-
formatics (with increasing numbers of applicants), with MUII 
alumni as heads of departments, supervisors and investigators 
in multi-disciplinary Infection and Immunity research (Table 2).
“Seeing these young Ugandans that have an interest in immu-
nology, seeing that interest develop, bud and flower into a 
full-blown passion for immunology and seeing them start thinking 
about their research in immunological terms and to start to 
Table 1. Infection and Immunity research trainees between January 
2008 and December 2019.
MUII-
funded Honorary Total
Female gender 
N (%)
Group Leaders 3 0 3 2 (67)
Post-docs 15 0 15 7 (47)
Doctoral students (PhD) 17 10 27 14 (52)
MSc students 18 5 23 11 (48)
Overall 53 15 68 34 (50)
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win grants in immunology! That for me is success” (EMEL028, M, 
KII, Centre Staff)
Sustainable training and research collaborations. Through 
MUII, fellows created and consolidated collaborations and 
networks with over 40 institutions globally. Illustrative examples 
are listed in Table 3. These institutions have supported training 
in fields such as genetics, antimicrobial resistance, systems biol-
ogy, bioinformatics, metagenomics, molecular and cell biology, 
vaccine development, and biomarker research (Table 3): fields in 
which world class expertise was limited in Uganda. In addition, 
these collaborations have helped to position fellows to achieve 
recognition internationally:
“…by linking me to Professors in the United Kingdom, it has 
really expanded my horizon because with them we have been 
able to compete at a bigger stage…Right now my light is shining 
because of this bigger stage that the collaboration has 
enabled me to get into. So it has really been very instrumental.” 
(EMEL015, M, IDI, Group Leader).
Challenges
However, interviewees reported several important challenges 
encountered.
Procurement. Delay in procurement of biological research 
supplies was reported as a critical challenge. Most government 
procurement systems did not have provision for direct orders 
from international suppliers of reagents specifically used in 
published immunology protocols, without the bureaucracy of 
local agents. This was a bottleneck to timely implementation 
of research and many fellows relied on international laboratory 
placements to complete their work. One fellow commented: “I 
spent most of my time in the lab overseas to avoid delays because 
Figure 2. Research outputs by MUII fellows between January 2008 and December 2019: A shows peer-reviewed publications and B) shows 
amount of research funding received. 
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that is where I could get my supplies continuously delivered 
almost immediately from the manufacturing company.” (EMEL004, 
F, IDI, Group Leader). Others mentioned the need to place 
orders directly with manufacturers to avoid local agents and 
procurement delays.
Nevertheless, the procurement teams at UVRI and Makerere 
worked together to understand the issues affecting the research-
ers and did their best within the allowable clauses and 
limitations in policies for procurement of research reagents and 
equipment.
Time management. A common challenge for fellows was to 
meet deadlines, and many mentioned that they had to balance 
research with their clinical and teaching responsibilities: 
“One still has to perform their roles as a clinician, teacher, 
researcher, Head of Department, wife, mother, etc.” (EMEL001, 
F, IDI, post-doc). Time pressure increased as fellows advanced 
in their research career.
Limited pool of clinical immunology and bioinformatics 
experts. Some fields had very limited local capacity for appli-
cation of immunology and bioinformatics tools to address 
Table 2. Growth in Infection and Immunity (I&I) Research at partner institutions Uganda Virus Research Institute and 
Makerere University.
MUII contribution Makerere University Uganda Virus Research Institute
Research support
Infrastructural 
development
Laboratories within College of Health Sciences and 
College of Veterinary Medicine, Animal Resources and 
Biosecurity Computer laboratory, College of Natural 
Sciences 
Training building with offices, meeting rooms and 
conferencing facilities and training laboratory 
IT equipment and, software for trainees Financial 
systems equipment and , software Support staff 
salaries and training
Laboratory capacity Technician Support and equipment to translational 
lab at Infectious Diseases Institute 
Technology transfer by fellows training abroad to 
utilise acquired skills upon return to parent institution
Training Laboratory management 
Laboratory equipment 
Technology transfer by fellows training abroad 
to utilise acquired skills upon return to parent 
institution
Infection and immunity 
training programmes
Developed short course: Immunology in the tropics 
Contributed to start of MSc Immunology and 
Molecular biology 
Video-conferenced expert seminars 
Supported one immunologist 
Support to MSc and PhD in bioinformatics
Strengthened bioinformatics core with masters, 
doctoral and post-doctoral trainees 
Supported one immunologist 
Supported one molecular biologist/
bioinformatician
Student supervision MUII trainees (MSc &PhD) were supervised by 
Makerere University faculty and collaborators 
MUII alumni continue to supervised MSc &PhD 
students
MUII trainees (MSc &PhD) were supervised by UVRI 
faculty and collaborators 
Supported one statistician to provide fellows’ 
statistical guidance
Leadership 
Research leadership MUII alumni are now heads of departments, Deans, 
and leaders of professional association boards
MUII alumni are now key investigators and 
collaborators on institutional and collaborative 
projects
Developing collaborations 
& networks
All PhD, post-doctoral and group-leader fellows have 
travel support for collaboration 
Competitive Travel awards for programme staff and 
trainees 
Symposia and seminars
All PhD, post-doctoral and group-leader fellows 
have travel support for collaboration 
Competitive Travel awards for programme staff 
and trainees
Engagement with 
research participants & 
policy makers
All fellows receive funds for engagement All fellows receive funds for engagement 
Open Days hosted at UVRI
Programme 
organisation
Support to existing schedules of supervisors’ and 
doctoral meetings in line with directorate of research 
and graduate training 
Support trainees to adhere to institutional research 
regulatory processes Internal monitoring of research
Administrative structure (secretariat) 
Executive Committee with representation of all the 
cadres, Masters, post-docs, PhDs 
Regular progress review meetings 
Monitoring & Evaluation 
Overarching Scientific Advisory Board of 
International experts in I&I
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challenging threats: for example, the field of maternal health 
for the challenge of pre-eclampsia. MUII responded to this 
challenge through the support of international collaborators 
(Table 3). Some of these collaborative efforts have resulted 
in lasting collaborations between fellows and supervisors, for 
example:
“The collaboration with Cambridge started with a PhD student 
and her mentor but now lots of other people involved in the 
health arena from Cambridge are working with her department. 
That is the ideal way we would like to see collaborations grow.” 
(EMEL029, F, KII, Centre Staff).
Uncertain sustainability of active research programmes 
beyond MUII. Maintaining active research beyond their 
MUII funding was a challenge for fellows, with the prospect 
of attracting funding appearing quite daunting: “I need real 
significant funding which can maintain a group or team of 
six people for three years. I also need support in terms of 
someone commenting on the proposal or application and 
being connected to people of similar interests.” (EMEL009, 
M, IDI, post-doc).
However, many fellows appreciated that this challenge was 
to be expected and competitive resource mobilisation is part 
of being a research scientist. To address this challenge, MUII 
organised skills-building meetings for fellows including grant 
writing and peer-review to increase the competitiveness of appli-
cations. In addition, MUII supports a mentorship programme 
where fellows can be linked to experts in their field.
Lessons learned regarding key contributors to success
Interviewees shared key lessons learned in capacity building 
for research in resource-limited settings.
Table 3. An illustrative sample of local and international collaborations with MUII between January 2008 and December 2019.
Collaborating institution (name and country) Area of focus Roles/contribution to MUII trainees
Uganda Virus Research Institute, Uganda Laboratory skills MUII programme host, statistics and 
bioinformatics core
Makerere University College of Heath Sciences, 
Uganda
Immunology, Bio-informatics, clinical 
care, patient cohorts
Masters and doctoral Programmes
Makerere University College of Natural Sciences, 
Uganda
Mathematical modelling Trainees, mentors and dry lab space
Makerere University College of Veterinary Medicine, 
Animal Resources and Bio-Security, Uganda
Laboratory strengthening 
Immunology
Trainees, mentors and wet lab space
Rakai Health Sciences Project, Uganda HIV pathogenesis and phylogenetics Community cohorts and wet labs
Cambridge University and Cambridge Africa 
programme, UK
Metagenomics Genetics of pre-
eclampsia
HLA typing, collaborative grant 
applications Training seminars
London School of Hygiene and Tropical Medicine, 
UK
Infection and Immunity Mentors, statistics core and Scientific 
advisory board membership
Gladstone Institute of Vaccine Immunology, San 
Francisco, USA
HIV pathogenesis Laboratory skills training and mentorship
The Vaccine and Gene Therapy Institute, Florida, 
USA
Systems biology Laboratory skills training, workshop 
facilitation and mentorship
Case Western Reserve University, Ohio, USA Systems biology Laboratory skills training, workshop 
facilitation and mentorship
The Jenner Institute, Oxford, UK Tuberculosis Vaccinology Laboratory skills training and mentorship
Addenbrooke’s Hospital, Cambridge, UK Genetics of pre-eclampsia Laboratory skills training and mentorship
University of St. Andrews, UK Antimicrobial resistance Laboratory skills training and mentorship
University of Edinburgh, UK Bioinformatics Training and mentorship
PANGEA Network Bioinformatics Training and mentorship
Imperial College London, UK Bioinformatics Training and mentorship
Sanger Institute, UK Metagenomics Training and mentorship
Leiden University Medical Center, Netherlands Parasite immunology and vaccines Laboratory skills training and mentorship
University of Geneva Human Protein Lab, 
Switzerland
Plasma staging biomarkers Laboratory skills training and mentorship
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Programme administration and organisation. Good operational 
management was key to success of the training and research 
programme (Figure 1 and Table 2). The distribution of roles 
to improve efficiency and the monitoring and evaluation func-
tions helped the fellows to adhere to research regulations and 
programme timelines for master’s and doctoral students. Hav-
ing an executive committee (EC) with representation from the 
different stakeholders including trainees and training institu-
tions helped to think through most challenges and provide clear 
solutions within the context. Similarly, having a secretariat to 
follow through the implementation of EC recommendations 
helped the program to keep track of any internal or external 
influencers of trainees’ progress. Many of the fellows were 
grateful for the support they had received to enable them to 
graduate.
“MUII has had 100% success of [Masters] graduation on time. 
The programme pays attention to the Fellows. I think it has been 
excellent in terms of mentorship of the Fellows...” (EMEL005, 
M, IDI, master’s).
Multi-disciplinary collaboration within Uganda between lead-
ing academic and research institutions. MUII showed that it 
was feasible to develop and sustain collaborations between 
UVRI and the Makerere Colleges of Health Sciences; Veteri-
nary Medicine, Animal Resources and Biosecurity; Natural Sci-
ences; and Computing and Information Sciences (Table 3). 
This collaborative infrastructure was appreciated by fellows as a 
strength:
“…I applied [for the Group Leader Position] because I 
thought it would really give this cross multi disciplinarity, not 
just being at Makerere University, but also interacting with 
other research institutions in Uganda. UVRI is a premiere research 
institution in this country. So I thought it would be an opportu-
nity for me to liaise with other scientists…” (EMEL015, M, IDI, 
Group Leader).
Procurement of research reagents and equipment. Public aca-
demic and research institutions need to be supported to foster 
active framework agreements with international manufactur-
ers of biological research reagents to minimise time delays 
created by looking for local agents who do not routinely import 
items that are specific to biological laboratory experiments and 
innovations.
Mentorship. Supporting young researchers to progress through 
MSc, PhD and post-doc programmes and subsequently to 
develop as group leaders to mentor other upcoming scientists 
and maintain the pipeline has been greatly valued.
“During the ten-year period, there were opportunities for 
MUII graduates at any level to apply (competing with other 
non-MUII applicants) for available MUII opportunities at the 
next level of career development. ‘I was privileged to have a 
very good supervisor and mentor who gave me time, gave my 
applications time and gave my research ideas time. So that I 
attribute to mentorship.” (EMEL001, F, IDI, post-doc).
Sustainability of I&I research. Most fellows and graduates of 
the MUII programme have been able to win career development 
and research grants to sustain their research groups. Fellows, 
however, mentioned their need for more technical support 
to respond to funding opportunities as well as additional training 
in community engagement, leadership, and data management.
“I think we’ve been a pretty good example across the whole 
DELTAS [funding programme] network in getting out early PhD 
Fellows and they are in a position of getting their own research 
grants, they are heads of departments, deans of faculties and 
they are running their own profile research. I think that is 
where the sustainability comes in.” (EMEL028, M, KII, Centre 
Staff).
Similarly, the MUII alumni that have grown professionally to 
take academic and research leadership positions are nurtur-
ing a culture that fosters high quality research in I&I research 
and are already mentoring other upcoming scientists.
“We have had a PhD funded fellow who is now working as 
Dean at the Vet School. We have a Group Leader who is the 
Dean of the Medical School. We have another Group Leader 
who has become a head of Department at Makerere University. 
So I think through them and other MUII alumni in other influen-
tial areas at Makerere University would make MUII and other 
research collaborations more sustainable.” (EMEL029, F, KII, 
Centre Staff).
“…I have six PhD students that I supervise and mentor but in 
addition to that I mentor many other gynaecologists, even stu-
dents outside my department…I mentor over 20 [students] 
because every time people come to consult me on different things.” 
(EMEL018, F, IDI, Group Leader).
Discussion
The MUII capacity-building programme in I&I has demon-
strated ten years of high quality training in emerging tools 
of immunology and bioinformatics to answer locally gener-
ated questions to address gaps in knowledge and practice in the 
dominating infections of HIV, tuberculosis, malaria and its com-
plications, helminths and emerging viruses, as well as the rising 
burden of non-communicable diseases including asthma, diabe-
tes, hypertension and pre-eclampsia6–32. Through the spectrum 
of fellowships provided, from the most junior of undergradu-
ate interns to master’s, doctoral, post-doctoral and group-leader 
awards, MUII has provided mentored research training oppor-
tunities to foster growth of academic research careers. With the 
engagement of scientific and non-scientific community, MUII 
scientists disseminated their science, its relevance in the local 
context and exposed it to over 5000 high school students (tomor-
row’s scientists). The impact has been demonstrated by the pro-
gramme monitoring and evaluation indicators that include, 
among others, peer-reviewed publications, additional funding 
for research and capacity building obtained by trainees, emer-
gence of multi-disciplinary research groups, increasing applicants 
to the new MUII-supported masters’ and doctoral programmes 
in immunology and bioinformatics, and number of active local 
and international collaborations.
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Unlike capacity-building initiatives that have focused on 
increasing the number of medical graduates for health care3,4 
and doctoral training in various fields5,33, MUII has focused 
on developing experts in I&I - a major gap that slackens local 
biomedical responses to emerging infections in Africa. In 
addition, MUII has embraced the challenge of technology trans-
fer of new immunology and bioinformatics techniques with 
the aim that MUII trainees will be empowered to lead novel 
initiatives like developing vaccine or therapeutic targets for 
emerging diseases. In a modest way, MUII tried to mimic what 
developing an academic research career would entail in high-
income settings, where a developing research group requires 
fellowship schemes to kick-start scientists, PhD students and 
post-docs to be part of novel ideas and publications, techni-
cians to support high-throughput equipment, dry laboratory sci-
entists for genomic analyses and mathematical modelling2. We 
recommend monitoring of equipment booking schedules to 
use wet laboratory equipment for immunology and molecu-
lar biology assays, abstracts presented at relevant local and 
international meetings, meetings held by our scientists with 
community, policymakers and other relevant stakeholders to 
demonstrate productivity and utility of the scientists. These 
are all critical for the next level of development of science in 
Africa. Improved management strategies are needed to tackle 
the epidemiological change facing Africa due to urbanisa-
tion and changes in lifestyle like the emerging burden of 
non-communicable diseases (NCDs) in Africa2. Appropri-
ate diagnostics, treatment and vaccines are needed in the face 
of unprecedented emerging pandemics, such as the current 
COVID-19 crisis. Locally generated evidence is critical to local 
management of such global pandemics; with examples of fast-
tracked clinical trial data emerging from China and USA34,35 and 
the reliance of countries on their leading scientists36 to inform 
national and global interventions. There is need for clinical 
trials within the local and cultural context of communities and 
health system. For example, it is not obvious that host responses 
to hydroxychloroquine and azithromycin as COVID-19 trial 
therapies in America would be similar to those in sub-Saharan 
Africa where both drugs have been used commonly for 
endemic malaria and atypical pneumonias, or that vaccines 
developed in high-income settings will be equally effective in 
Africa.
The MUII experience is unprecedented because of the previ-
ous absence of local advanced training programmes (MSc and 
doctoral level) in immunology and bioinformatics to advance 
locally trained scientists in I&I research. It is important 
to note that growing I&I scientists for public utility and cre-
ating a culture of mentored research opportunities for jun-
ior and mid-level scientists may take several years to decades; 
and even longer for institutions to attain critical mass of scien-
tists with a culture of mentoring. Therefore, the lessons learned 
over the decade of implementation of the programme, presented 
here, are noteworthy to inform ongoing and future capacity 
building programmes on the African continent.
We have learned the need for a dedicated secretariat to sup-
port training programmes with communication, tracking, and 
evaluation to ensure timely completion of programme mile-
stones. It is also critical for training programmes to provide 
technical expertise where it is needed for the success of train-
ees. MUII supported two immunologists to be part of the new 
department of Immunology and Molecular Biology that is 
chaired by a former MUII post-doc. Similar input was previ-
ously illustrated by an ongoing capacity building programme for 
cancer research that protected support staff time of approxi-
mately 0.25 to 0.5 full-time equivalents contributed to the 
success of the programme37. During the regular programme 
capacity building meetings, fellows would critique each oth-
er’s work, which greatly improved the quality of proposals and 
presentations. Fellows also had opportunities to participate in 
different workshops and conferences. MUII fellows were pre-
pared to become better mentors, and many of them acquired peer 
mentees, as previously noted that peer mentorship greatly sup-
ported in-country capacity building initiatives37. At the regular 
progress meetings fellows discussed bottlenecks in their progress 
such as delayed procurement of specific reagents and equipment 
that required direct importation from manufacturers 
abroad. Both MUII institutions (UVRI and Makerere) still 
need support to develop and implement efficient policies 
that reduce the turn-around time for research reagents and 
equipment orders, many of which are expensive sole sup-
plier items because of previously optimised protocols and 
equipment38.
MUII programme increased trainees’ networking opportuni-
ties through the large pool of multi-disciplinary scientists and 
through several collaborations established as well as the visit-
ing scientist awards where fellows also had opportunities to 
invite expert scientists to support training and research locally. 
For example, as part of a visiting award, the translational immu-
nology group led by Damalie Nakanjako (Physician) invited 
an expert in multicolour flowcytometry (Glenda Canderan 
from the Department of Pathology at Case Western Reserve 
University, USA) to support the team through their large 
flowcytometry panels using the 20-color LSRII flowcytometer at 
UVRI campus. Subsequently the team published important results 
that demonstrated persistent innate immune dysfunction (NK 
cells, monocytes and Innate lymphoid cells) despite long-term 
antiretroviral therapy23–25. Similarly, maternal health group, led 
by Annettee Nakimuli (Obstetrician and Gynaecology), through 
Ashley Moffet and Corina Alberg provided several opportunities 
for Uganda’s junior scientists to network and collaborate with 
experts in the field of KIR genes and their role in pre-eclampsia 
which is the leading cause of poor maternal and fetal 
outcomes in Uganda26,39. Subsequently two more PhD students 
are being trained in this field on the programme. In addition, 
Makerere University graduate trainees (MSc and doctoral) and 
staff in Immunology and Bioinformatics attend regular remote 
seminars provided by Cambridge University using the WebEx 
(Cisco WebEx, Milpitas, CA).
Each of MUII’s PhD and post-doctoral Fellows had the oppor-
tunity to travel as they had to have an international collabora-
tor as well as local collaborators. That approach multiplied 
the collaborations by the number of fellows. In a survey of a 
cancer research capacity building programme, training doc-
toral students and fellows, only 3/38 (7%) had adequate oppor-
tunities to network with other researchers37. Our involvement 
of world-class experts in the fields of interest helped to mitigate 
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the previously noted challenge of limited experts to mentor 
emerging scientists in Uganda40,41. Collaborators/co-supervisors 
and co-mentors were key elements in the programme because of 
the limited critical mass of mid-and-advanced career scientists 
in the country. In the past, many of Uganda’s experts were scat-
tered globally due to cultural, geopolitical and socio-economic 
drivers of brain drain37,38,41. Fellows highlighted that MUII 
provided them a lot of exposure that opened several opportuni-
ties to pursue careers in research. The multi-disciplinary nature 
of the collaborations established by MUII has birthed long-term 
bonds with the participating institutions of LSHTM, Cambridge 
University and the Sanger Institute, among others; which will 
continue to be utilised by students and faculty beyond the MUII 
funding. A limitation of this study is the low survey response 
of 40% which could bias our findings if most of the respond-
ers had been successful trainees; however, this may not 
affect our results because we received both positive and 
negative reviews in FGDs and reached saturation of ideas with 
this sample size. We also found that emerging themes from 
the trainees in FGDs were complementary to those from key 
informant interviews.
Conclusion
MUII demonstrated a decade of mentored academic productiv-
ity in I&I research. Its sustainability is evidenced by the continu-
ing mentorship, research groups, training programmes, resource 
mobilisation and global collaborations that have emerged 
to contribute to solutions to Africa’s health care problems. More 
skills and commitment remain necessary for trainees in develop-
ing countries to compete favourably for international research 
funding to build and sustain a critical mass of I&I scientists, to 
respond to current and emerging health problems.
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I have read the manuscript, it is well written. Having said that, below are some suggestions to 
improve the article;  
In the introduction the authors mention post-doctoral and group leaders as early-career 
scientists, it would be of benefit to explain the difference between these two categories. 
 
1. 
Methods: The authors mention a secretariat and an executive committee (both headed by 
the director) managing the implementation of the programme. Also mentioned is an 
efficient administration that provides an enabling environment. 
 
What is the enabling environment?1. 
What is the role of secretariat if the management of the programme is done by the 
executive committee?
2. 
It would be helpful to understand the difference in the roles above and why? What 
are the successes, changes and key lessons learned from this arrangement?
3. 
How the two (in b above) that separated from the UVRI administrative structure 
mentioned in table 2?
4. 
The authors can explain the limitations of purposefully selecting the 27 trainees from 
the small pool of 68 trainees. 
 
5. 
2. 
 Both EMEL029, F, IDI, KII, Centre Staff & EMEL018, F, IDI, Group Leader mention Obs and 
Gyn Department and mentoring of gynaecologists, the authors have not mentioned this 
group anywhere else.    
 
3. 
Table 2: 
 
As MUII’s contribution to laboratory capacity is ‘technology transfer by fellows 
training abroad’ – what is the authors’ definition of ‘technology transfer’?
1. 
Please expound on the “…human, technical and physical infrastructural development 2. 
4. 
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in I&I capacity” that MUII has contributed to at partner institutions.
Research leadership and developing collaborations & networks are not categorized as 
scientific citizenship under DELTAS Africa. 
 
3. 
Results: the authors have described success and career progression of trainees.   
 
It would be informative to show the number of fellows that grew through the ranks 
(from masters through to early career).
1. 
How long does it take to grow I&I scientists for public utility? Describe the support 
referred to under mentorship.
2. 
Is the growth and success of the fellows in leadership roles totally attributed to MUII? 
  
 
3. 
5. 
Under sustainable training and research collaboration the authors mention fields in which 
world-class expertise was not available in Uganda – is there evidence for this? Was the 
expertise limited or totally not available?
6. 
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I have read the manuscript thoroughly and the study has scientific basis and the document is well 
written. However, below are some of the improvements that can be made:
The introduction is rather brief and some of the information presented under the discussion 
can be useful to inform the introduction. 
 
1. 
The methods: 
- The methods are well described. The authors should consider describing how consistency 
and trustworthiness of the data was ensured in this study. Such information is important in 
qualitative studies. 
- The authors have described (under qualitative data management) that data was analysed 
thematically. A table indicating the major themes and sub-themes generated and also the 
meaning of each would add value to the manuscript. Clear definitions of themes and 
subthemes would enhance understanding the description under results, the quotations as 
evidence on the themes. 
 
2. 
Results: 
- The characteristics of respondents will add value to the manuscript of a table on 
demographic characteristics of the respondents could be provided. Table 1 is all about the 
achievements rather than who provided the information. 
- It appears from the results that only two major themes have been discussed i.e. 
achievements and challenges. This section should be structured to reflect the major themes 
cited under methods. Introduce sub-heading e.g. Achievements, Good practices, lesson 
learnt, recommendations for improvements etc. 
 
3. 
Discussion: 
- The discussion is well written but paragraph 5 is probably best placed under methods. This 
paragraph discusses establishment of a secretariat, an operational overseeing structure, 
therefore not part of the results. 
- The discussion should provide some of the recommendations made by respondents. 
 
4. 
Graphs and tables: 
The tables available are well presented. Check figure 2(B) on the y-axis, the UK Sterling 
Pound is written in plural (Pounds). 
 
5. 
Typo/grammatical errors: 6. 
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Check under "Data availability", line 4, after the name "Nakanjako" there is Flavia Zalwango. 
Delete because it is repeated on the next line 5.
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